Boedigheimer, M. J., Martin, D. A., Amoura, Z., Sánchez-Guerrero, J., Romero-Diaz, J., Kivitz, A., . . . Chung, J. B. (2017). Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis. Lupus science & medicine, 4(1), e000226. https://doi.org/10.1136/lupus-2017-000226
Chicago Style (17th ed.) CitationBoedigheimer, Michael J., et al. "Safety, Pharmacokinetics and Pharmacodynamics of AMG 811, an Anti-interferon-γ Monoclonal Antibody, in SLE Subjects Without or with Lupus Nephritis." Lupus Science & Medicine 4, no. 1 (2017): e000226. https://doi.org/10.1136/lupus-2017-000226.
MLA (9th ed.) CitationBoedigheimer, Michael J., et al. "Safety, Pharmacokinetics and Pharmacodynamics of AMG 811, an Anti-interferon-γ Monoclonal Antibody, in SLE Subjects Without or with Lupus Nephritis." Lupus Science & Medicine, vol. 4, no. 1, 2017, p. e000226, https://doi.org/10.1136/lupus-2017-000226.